US precision oncology company Boundless Bio (Nasdaq: BOLD) has announced financial results and business highlights for the ...

US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

A Feature on M&A, VC investment, licensing and partnerships in the radiopharmaceuticals arena.